Effect of genetic polymorphisms on development of gout

Journal of Rheumatology

Volumn 40, Issue 8, 2013, Pages 1374-1378

  Urano, Wako ^a   Taniguchi, Atsuo ^a   Inoue, Eisuke ^a,b   Sekita, Chieko ^a   Ichikawa, Naomi ^a   Koseki, Yumi ^a   Kamatani, Naoyuki ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Gout; Single nucleotide polymorphisms; Uric acid

Indexed keywords

URIC ACID;

ADULT; ARTICLE; CELL COUNT; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GOUT; HEREDITY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; URIC ACID BLOOD LEVEL; VALIDATION STUDY;

GOUT; SINGLE-NUCLEOTIDE POLYMORPHISMS; URIC ACID;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GOUT; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; URIC ACID;

EID: 84881400090     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.121244     Document Type: Article

References (36)

1. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey; 2007-2008. Arthritis Rheum 2011;63:3136-41.
2. Smith EU, Diaz-Torne C, Perez-Ruiz F, March LM. Epidemiology of gout: an update. Best Pract Res Clin Rheumatol 2010;24:811-27.
3. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007;116:894-900.
4. Hak AE, Choi HK. Lifestyle and gout. Curr Opin Rheumatol 2008;20:179-86.
5. Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007;3:e194.
6. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008;40:437-42.
7. Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008;40:430-6.
8. Wallace C, Newhouse S, Braund P, Zhang F, Tobin M, Falchi M, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008;82:139-49.
9. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009;5:e1000504.
10. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6.
11. Kamatani Y, Matsuda K, Okada Y, Kubo M, Hosono N, Daigo Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet 2010;42:210-5.
12. Taniguchi A, Urano W, Yamanaka M, Yamanaka H, Hosoyamada M, Endou H, et al. A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout. Arthritis Rheum 2005;52:2576-7.
13. Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y, et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 2009;1:5ra11.
14. Urano W, Taniguchi A, Anzai N, Inoue E, Kanai Y, Yamanaka M, et al. Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis 2010;69:1232-4.
15. Urano W, Taniguchi A, Anzai N, Inoue E, Sekita C, Endou H, et al. Association between GLUT9 and gout in Japanese men. Ann Rheum Dis 2010;69:932-3.
16. Wallace S, Robinson H, Masi A, Decker J, McCarty D, Yu T. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
17. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007;11:41-50.
18. Kamatani N, Sekine A, Kitamoto T, Iida A, Saito S, Kogame A, et al. Large-scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense SNP maps, of 199 drug-related genes in 752 subjects: the analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs. Am J Hum Genet 2004;75:190-203.
19. International Hap Map project. [Internet. Accessed May 3, 2013.] Available from: http://hapmap.ncbi.nlm.nih.gov/
20. Miyake K, Yang W, Hara K, Yasuda K, Horikawa Y, Osawa H, et al. Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J Hum Genet 2009;54:236-41.
21. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
22. Ohman EM, Granger CB, Harrington RA, Lee KL. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA 2000;284:876-8.
23. Dehghan A, Kottgen A, Yang Q, Hwang S-J, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008;372:1953-61.
24. van der Harst P, Bakker SJ, de Boer RA, Wolffenbuttel BH, Johnson T, Caulfield MJ, et al. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet 2010;19:387-95.
25. Tabara Y, Kohara K, Kawamoto R, Hiura Y, Nishimura K, Morisaki T, et al. Association of four genetic loci with uric acid levels and reduced renal function: The J-SHIPP Suita Study. Am J Nephrol 2010;32:279-86.
26. Yang Q, Kottgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010;3:523-30.
27. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008;359:2208-19.
28. Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, Kumari M, et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 2010;340:b4838.
29. Qi Q, Li H, Wu Y, Liu C, Wu H, Yu Z, et al. Combined effects of 17 common genetic variants on type 2 diabetes risk in a Han Chinese population. Diabetologia 2010;53:2163-6.
30. Li S, Zhao JH, Luan J, Luben RN, Rodwell SA, Khaw KT, et al. Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies. Am J Clin Nutr 2010;91:184-90.
31. Anderson JL, Horne BD, Camp NJ, Muhlestein JB, Hopkins PN, Cannon-Albright LA, et al. Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease. Am Heart J 2010;160:250-6.
32. De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, Simon KC, et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 2009;8:1111-9.
33. Gunjaca G, Boban M, Pehli M, Zemunik T, Budimir D, Kolci I, et al. Predictive value of 8 genetic loci for serum uric acid concentration. Croat Med J 2010;51:23-31.
34. Cornelis MC, Qi L, Zhang C, Kraft P, Manson JA, Cai T, et al. Joint effects of common genetic variants on the risk for type 2 diabetes in US men and women of European ancestry. Ann Intern Med 2009;150:541-50.
35. Choi H, Ford E, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007;57:109-15.
36. Kuo CF, See LC, Luo SF, Ko YS, Lin YS, Hwang JS, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology 2009;49:141-6.